Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 144 (1) , 359-366
- https://doi.org/10.1016/s0006-291x(87)80518-1
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Desensitization of human platelets by platelet activating factorBiochemical and Biophysical Research Communications, 1985
- Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by TriazolobenzodiazepinesScience, 1984
- Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human plateletsBiochemical Journal, 1984
- Specific binding of phospholipid platelet-activating factor by human platelets.The Journal of Immunology, 1982
- Subcellular localization and secretion of factor V from human platelets.Proceedings of the National Academy of Sciences, 1981
- Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).Journal of Biological Chemistry, 1979
- The aggregation of blood plateletsThe Journal of Physiology, 1963